Hydrazines
- Name
- Hydrazines
- Accession Number
- DBCAT000469
- Description
Substituted derivatives of hydrazine (formula H2N-NH2).
- Drugs
Drug Drug Description Carbidopa A dopa decarboxylase inhibitor used in combination with levodopa for the symptomatic treatment of idiopathic Parkinson disease and other conditions associated with parkinsonian symptoms. Phenelzine A monoamine oxidase inhibitor used to treat atypical, nonendogenous, or neurotic depression. Isoniazid An antibiotic used to treat mycobacterial infections; most commonly use in combination with other antimycobacterial agents for the treatment of active or latent tuberculosis. Iproniazid For the treatment of depression (originally intended to treat tuberculosis). Benserazide A medication used to treat Parkinson's disease, parkinsonism, and restless leg syndrome. Levosimendan A calcium sensitizer indicated to treat acutely decompensated severe chronic heart failure. Balsalazide An aminosalicylate used to treat ulcerative colitis. Apilimod Investigated for use/treatment in crohn's disease and psoriasis and psoriatic disorders. Sivifene Investigated for use/treatment in cervical dysplasia/cancer, genital warts, and skin cancer. Aldoxorubicin Investigated for use/treatment in solid tumors. Semapimod Semapimod has been used in trials studying the treatment of Crohn Disease. VP-14637 MDT-637 has been investigated for the treatment of Drug Safety. Simendan Simendan is under investigation in clinical trial NCT00527059 (Renal Effects of Levosimendan in Patients Admitted With Acute Decompensated Heart Failure). Meldonium Not Annotated Dynasore Not Annotated Hetrombopag Hetrombopag is under investigation in clinical trial NCT03976882 (Hetrombopag for the Treatment of Chemotherapy-induced Thrombocytopenia in Subjects With Malignancy.). PIK-75 PIK-75 is a preferential p110 alpha/gamma PI3K inhibitor. Aconiazide Not Annotated - Drugs & Drug Targets